Free Trial

Cocrystal Pharma (COCP) Competitors

Cocrystal Pharma logo
$2.25 +0.15 (+7.14%)
(As of 12/20/2024 05:51 PM ET)

COCP vs. KPTI, QNCX, GNLX, PMVP, ENTX, CLSD, IMAB, ELYM, IKNA, and GBIO

Should you be buying Cocrystal Pharma stock or one of its competitors? The main competitors of Cocrystal Pharma include Karyopharm Therapeutics (KPTI), Quince Therapeutics (QNCX), Genelux (GNLX), PMV Pharmaceuticals (PMVP), Entera Bio (ENTX), Clearside Biomedical (CLSD), I-Mab (IMAB), Eliem Therapeutics (ELYM), Ikena Oncology (IKNA), and Generation Bio (GBIO). These companies are all part of the "pharmaceutical products" industry.

Cocrystal Pharma vs.

Karyopharm Therapeutics (NASDAQ:KPTI) and Cocrystal Pharma (NASDAQ:COCP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership, community ranking and risk.

Karyopharm Therapeutics has a beta of 0.05, indicating that its share price is 95% less volatile than the S&P 500. Comparatively, Cocrystal Pharma has a beta of 1.52, indicating that its share price is 52% more volatile than the S&P 500.

Cocrystal Pharma has a net margin of 0.00% compared to Karyopharm Therapeutics' net margin of -58.93%. Karyopharm Therapeutics' return on equity of 0.00% beat Cocrystal Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Karyopharm Therapeutics-58.93% N/A -41.25%
Cocrystal Pharma N/A -94.62%-78.24%

In the previous week, Karyopharm Therapeutics' average media sentiment score of 0.00 equaled Cocrystal Pharma'saverage media sentiment score.

Company Overall Sentiment
Karyopharm Therapeutics Neutral
Cocrystal Pharma Neutral

Karyopharm Therapeutics received 512 more outperform votes than Cocrystal Pharma when rated by MarketBeat users. However, 76.67% of users gave Cocrystal Pharma an outperform vote while only 72.20% of users gave Karyopharm Therapeutics an outperform vote.

CompanyUnderperformOutperform
Karyopharm TherapeuticsOutperform Votes
535
72.20%
Underperform Votes
206
27.80%
Cocrystal PharmaOutperform Votes
23
76.67%
Underperform Votes
7
23.33%

66.4% of Karyopharm Therapeutics shares are owned by institutional investors. Comparatively, 6.7% of Cocrystal Pharma shares are owned by institutional investors. 4.3% of Karyopharm Therapeutics shares are owned by insiders. Comparatively, 25.6% of Cocrystal Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Karyopharm Therapeutics currently has a consensus target price of $5.00, suggesting a potential upside of 687.40%. Cocrystal Pharma has a consensus target price of $7.00, suggesting a potential upside of 211.11%. Given Karyopharm Therapeutics' higher probable upside, analysts plainly believe Karyopharm Therapeutics is more favorable than Cocrystal Pharma.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Karyopharm Therapeutics
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00
Cocrystal Pharma
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Cocrystal Pharma has lower revenue, but higher earnings than Karyopharm Therapeutics. Cocrystal Pharma is trading at a lower price-to-earnings ratio than Karyopharm Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Karyopharm Therapeutics$148.44M0.54-$143.10M-$1.14-0.56
Cocrystal PharmaN/AN/A-$17.98M-$1.85-1.22

Summary

Karyopharm Therapeutics beats Cocrystal Pharma on 9 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COCP vs. The Competition

MetricCocrystal PharmaPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$22.89M$6.58B$5.13B$9.07B
Dividend YieldN/A2.99%5.08%4.23%
P/E Ratio-1.2210.4689.5817.17
Price / SalesN/A195.791,116.12116.95
Price / CashN/A57.1642.8237.86
Price / Book0.875.094.774.78
Net Income-$17.98M$151.83M$120.15M$225.60M
7 Day Performance17.92%-2.13%-1.92%-1.23%
1 Month Performance4.65%-3.10%11.47%3.36%
1 Year Performance19.05%11.54%30.52%16.60%

Cocrystal Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COCP
Cocrystal Pharma
2.6621 of 5 stars
$2.25
+7.1%
$7.00
+211.1%
+21.6%$22.89MN/A-1.2210High Trading Volume
KPTI
Karyopharm Therapeutics
3.8015 of 5 stars
$0.66
-5.3%
$5.00
+654.1%
-16.2%$83.67M$148.44M-0.61380
QNCX
Quince Therapeutics
2.8954 of 5 stars
$1.88
-7.4%
$8.50
+352.1%
+60.4%$82.72MN/A-1.6460Analyst Forecast
Analyst Revision
News Coverage
GNLX
Genelux
0.8843 of 5 stars
$2.39
+2.6%
$18.25
+663.6%
-82.9%$82.55M$8,000.00-2.4510
PMVP
PMV Pharmaceuticals
1.7944 of 5 stars
$1.59
+0.3%
$5.80
+265.9%
-34.5%$82.02MN/A0.0050Positive News
ENTX
Entera Bio
1.4305 of 5 stars
$2.21
+2.3%
$10.00
+352.5%
+195.8%$79.07M$130,000.00-8.5020
CLSD
Clearside Biomedical
2.8771 of 5 stars
$1.03
+1.0%
$5.33
+417.8%
-12.8%$78.12M$8.23M-2.2930News Coverage
IMAB
I-Mab
2.5162 of 5 stars
$0.95
-5.1%
$8.00
+742.6%
-38.9%$77.38M$3.27M0.0034Gap Down
ELYM
Eliem Therapeutics
N/A$2.60
-7.8%
N/A-27.5%$77.36MN/A-4.9120
IKNA
Ikena Oncology
2.8725 of 5 stars
$1.58
-4.2%
$3.00
+89.9%
-20.5%$76.25M$659,000.00-1.3470
GBIO
Generation Bio
2.7569 of 5 stars
$1.14
-1.7%
$7.50
+557.9%
-30.0%$76.14M$18.58M-0.53150Positive News

Related Companies and Tools


This page (NASDAQ:COCP) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners